Transgenomic Will Move to Nasdaq's Cap Market, Has Until Feb. 12 to Regain Compliance | GenomeWeb
NEW YORK (GenomeWeb News) – Transgenomic yesterday said that the Nasdaq Exchange has given the company an additional 180 calendar days, or until Feb. 12, 2007, to regain compliance with its minimum $1 bid requirement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.